Daniel Wipfli
Key Person Risk Indicator
This person currently holds 40 active roles across different companies. Concentration of board-level responsibility in a single individual may represent governance risk.
Companies
40 total roles
Active Roles
Currently active
Longest Tenure
Across all roles
Role History
| Company | Role | Category | Since | Until | Status |
|---|---|---|---|---|---|
| Friedrich Miescher Institute for Biomedical Research CHE-182.477.917 Active | Director | Management | — | — | Active |
| Triangle International Reinsurance Limited, Hamilton, Basel Branch CHE-376.047.716 Active | Authorised Signatory | Signatory | — | — | Active |
| Triangle International Reinsurance Limited, Hamilton, Basel Branch CHE-376.047.716 Active | Unknown | Board | — | — | Active |
| Novartis Pharma Schweiz AG CHE-106.015.756 Active | Unknown | Board | — | — | Active |
| Friedrich Miescher Institute for Biomedical Research CHE-182.477.917 Active | Unknown | Board | — | — | Active |
| Japat SA CHE-101.688.221 Active | Unknown | Board | — | — | Active |
| Novartis AG CHE-103.867.266 Active | Unknown | Board | — | — | Active |
| Novartis Stiftung für Mensch und Umwelt CHE-110.409.319 Active | Unknown | Board | — | — | Active |
| Novartis Lateinamerika AG CHE-102.750.006 Active | Unknown | Board | — | — | Active |
| Novartis Holding AG CHE-103.959.690 Active | Unknown | Board | — | — | Active |
| Novartis Overseas Investments SA CHE-103.011.259 Active | Unknown | Board | — | — | Active |
| Renor Inc. CHE-103.011.124 Active | Unknown | Board | — | — | Active |
| Renor Inc. CHE-103.011.124 Active | Unknown | Board | — | — | Active |
| Renor Inc. CHE-103.011.124 Active | Unknown | Board | — | — | Active |
| Novartis Pharma Stein AG CHE-108.644.360 Active | Unknown | Board | — | — | Active |
| Bad Schauenburg AG CHE-100.443.450 Active | Unknown | Board | — | — | Active |
| Novartis Pharma Services AG CHE-103.882.596 Active | Unknown | Board | — | — | Active |
| Novartis Innovative Therapies Ltd. CHE-346.820.682 Active | Unknown | Board | — | — | Active |
| Novartis Innovative Therapies Ltd. CHE-346.820.682 Active | Unknown | Board | — | — | Active |
| Novartis Innovative Therapies Ltd. CHE-346.820.682 Active | Unknown | Board | — | — | Active |
| Novartis Pharma AG CHE-106.052.527 Active | Unknown | Board | — | — | Active |
| Novartis International AG CHE-106.054.058 Active | Unknown | Board | — | — | Active |
| Novartis Pharma Schweizerhalle SA CHE-105.902.146 Active | Unknown | Board | — | — | Active |
| Friedrich Miescher Institute for Biomedical Research CHE-182.477.917 Active | Unknown | Board | — | — | Active |
| Novartis Stiftung für Mensch und Umwelt CHE-110.409.319 Active | Unknown | Board | — | — | Active |
| Triangle International Reinsurance Limited, Hamilton, Basel Branch CHE-376.047.716 Active | Unknown | Board | — | — | Active |
| Novartis Lateinamerika AG CHE-102.750.006 Active | Unknown | Board | — | — | Active |
| Novartis Pharma Schweiz AG CHE-106.015.756 Active | Unknown | Board | — | — | Active |
| Bad Schauenburg AG CHE-100.443.450 Active | Unknown | Board | — | — | Active |
| Novartis Holding AG CHE-103.959.690 Active | Unknown | Board | — | — | Active |
| Novartis Pharma Stein AG CHE-108.644.360 Active | Unknown | Board | — | — | Active |
| Novartis Pharma Services AG CHE-103.882.596 Active | Unknown | Board | — | — | Active |
| Novartis International AG CHE-106.054.058 Active | Unknown | Board | — | — | Active |
| Japat AG CHE-101.688.221 Active | Unknown | Board | — | — | Active |
| Novartis Bioventures Ltd. CHE-277.565.870 Active | Unknown | Board | — | — | Active |
| Novartis Pharma Schweizerhalle AG CHE-105.902.146 Active | Unknown | Board | — | — | Active |
| Novartis Bioventures Ltd. CHE-277.565.870 Active | Unknown | Board | — | — | Active |
| Novartis Pharma Schweizerhalle AG CHE-105.902.146 Active | Unknown | Board | — | — | Active |
| Sandoz Pharmaceuticals AG CHE-107.168.368 Active | Unknown | Board | — | — | Active |
| Sandoz Pharmaceuticals AG CHE-107.168.368 Active | Unknown | Board | — | — | Active |